UNSPSC 51122300: Cardioplegic agents

This classification denotes drugs that temporarily cause cardiac activity to cease.

UNSPSC 51122300 Cardioplegic agents is a Class code covering advanced life support and emergency cardiac medications sourced by state and local health agencies, emergency services, and cooperative purchasing alliances. State and local governments buy under this code specific injectable medications used in emergency response and cardiac care — epinephrine, adenosine, labetalol, and diltiazem formulations — procured through sealed competitive bids, RFPs, and cooperative purchasing agreements. Issuing bodies include city fire and rescue departments (represented by the City of Tampa's Tampa Fire Rescue), state health and human services commissions, and multistate cooperative purchasing alliances. The City of Tampa Purchasing Department and the Texas Health and Human Services Commission are recent active buyers. Work being solicited ranges from direct supply of individual medication units with firm pricing and rapid delivery cycles to participation in state-level cooperative purchasing networks serving multiple jurisdictions across different states.

Recent opportunities span Florida, Texas, and the upper Midwest. The City of Tampa issued sealed-bid solicitation 26P00188 in April 2026 for Advanced Life Support Medications (response deadline April 8, 2026) requiring supply of 370 units of Labetalol, 1,810 units of Epinephrine 1:10,000, 330 units of Adenosine 6mg, and 1,020 units of Diltiazem 25mg with nine-month minimum shelf life, firm freight-on-board pricing, and delivery within ten calendar days; the estimated contract value was $40,000, with a one-year base term and two optional one-year renewals, subject to a Small Local Business Enterprise sheltered-market designation with 5 percent bid discount. The Minnesota Department of Administration's Office of State Procurement issued RFP S1070000015802 through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon (response deadline March 26, 2026), requiring manufacturers to supply products through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) with awards effective July 1, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 in March 2026 exploring direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager and group purchasing organization channels, indicating preliminary market research ahead of formal solicitation.